Aarti Drugs Ltd (AARTIDRUGS) — Voting Results | 26 September 2026
At the 41st AGM on September 26, 2026, shareholders approved all 16 resolutions with overwhelming majorities, including the appointment of directors, retirement of Uday Patil, and approval of the Performance Stock Option Plan 2026. The financial statements for FY2026 were adopted with 99.999% support. No resolutions failed, and all passed with requisite majority under Companies Act 2013.
About Aarti Drugs Ltd (AARTIDRUGS)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when AARTIDRUGS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track AARTIDRUGS — Free💡 Ask AI about this filing
📊 More AARTIDRUGS filings
- 🟡 Board Meeting — 2 September 2026No summary available
- 🟡 Sustainability Report — 2 September 2026Aarti Drugs Limited submitted its Business Responsibility and Sustainability Report for FY 2025-26 t...
- 🔴 Annual Report — 2 September 2026No summary available
- 🟡 Board Meeting — 27 August 2026The board approved the Aarti Drugs Limited Performance Stock Option Plan 2026, authorizing up to 800...
- Board Meeting — 24 August 2026Aarti Drugs Limited announced its board will meet on August 27, 2026, to approve the Performance Sto...
🔥 Also filed on 26 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AARTIDRUGS files new disclosures
Track AARTIDRUGS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AARTIDRUGS — FreeFree account · 2 AI queries/day